147 related articles for article (PubMed ID: 16769590)
21. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
[TBL] [Abstract][Full Text] [Related]
22. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.
Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S
Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism in a young woman with combined homozygosity for factor V Leiden and prothrombin G20210A mutations.
Leonard M; Gala JL; Verschuren F; Coche E; Deneys V; Hainaut P
Haematologica; 2005 Nov; 90 Suppl():ECR30. PubMed ID: 16266921
[No Abstract] [Full Text] [Related]
25. Oral contraceptives and stroke.
Bousser MG; Kittner SJ
Cephalalgia; 2000 Apr; 20(3):183-9. PubMed ID: 10997772
[TBL] [Abstract][Full Text] [Related]
26. Thrombophilia and stroke.
Green D
Top Stroke Rehabil; 2003; 10(3):21-33. PubMed ID: 14681817
[TBL] [Abstract][Full Text] [Related]
27. Consequences of thrombophilia screening for life quality in women before prescription of oral contraceptives and family members of VTE patients.
Eichinger S
Hamostaseologie; 2009 Jan; 29(1):110-1. PubMed ID: 19151859
[TBL] [Abstract][Full Text] [Related]
28. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
29. A Study on Hereditary Thrombophilia and Stroke in a Cohort from Sri Lanka.
Kalpage HA; Sumathipala DS; Goonasekara HW; Dissanayake VH
J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):102-9. PubMed ID: 26522268
[TBL] [Abstract][Full Text] [Related]
30. Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.
Tasdemir S; Erdem HB; Sahin I; Ozel L; Ozdemir G; Eroz R; Tatar A
Neuromolecular Med; 2016 Jun; 18(2):170-6. PubMed ID: 26951304
[TBL] [Abstract][Full Text] [Related]
31. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
[TBL] [Abstract][Full Text] [Related]
32. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
[TBL] [Abstract][Full Text] [Related]
33. Ischemic stroke risk in oral contraceptive users.
Ciccone A; Melis M
Stroke; 2003 Dec; 34(12):e231; author reply e231. PubMed ID: 14631089
[No Abstract] [Full Text] [Related]
34. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use.
Dulicek P; Ivanova E; Kostal M; Sadilek P; Beranek M; Zak P; Hirmerova J
Clin Appl Thromb Hemost; 2018 Jul; 24(5):797-802. PubMed ID: 28884608
[TBL] [Abstract][Full Text] [Related]
36. Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis.
Martinelli I; Taioli E; Bucciarelli P; Akhavan S; Mannucci PM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):700-3. PubMed ID: 10073976
[TBL] [Abstract][Full Text] [Related]
37. Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
Santamaría A; Mateo J; Oliver A; Menéndez B; Souto JC; Borrell M; Soria JM; Tirado I; Fontcuberta J
Haematologica; 2001 Sep; 86(9):965-71. PubMed ID: 11532625
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
39. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
40. Stroke in users of low-dose oral contraceptives.
Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
